Related Experiment Video
Updated: Aug 14, 2026
Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
Published on: March 12, 2015
[Evaluation of the diagnostics pasteur platelia toxo IgG, IgM and IgA kits using Toxoplasma gondii major surface
Abstract:
1. Newly developed diagnostic kit for toxoplasma infection, Platelia Toxo IgG, IgM and IgA were compared with IFA IgG and IgM, revealing high co-positivity between the results obtained by the two methods. 2. The serum containing antinuclear antibody, rheumatoid factor and so on, which are often regarded as cause of false positive results, showed no nonspecific reaction completely. 3. Platelia Toxo IgM and IgA were applied for the serum obtained from the patients who were laboratory infected and/or acquired toxoplasma infection, most of the specimen revealing IgM and IgA antibody at the acute stage of the infection.
Insights
A new diagnostic kit for toxoplasma infection shows high accuracy, correctly identifying IgG, IgM, and IgA antibodies. It avoids false positives and detects antibodies during the acute infection stage.
Area of Science:
- Medical diagnostics
- Immunology
- Infectious diseases
Context:
- Toxoplasma infection diagnosis relies on serological methods.
- Existing methods may have limitations in specificity and sensitivity.
- A novel diagnostic kit, Platelia Toxo IgG, IgM, and IgA, has been developed.
Purpose:
- To evaluate the performance of the newly developed Platelia Toxo IgG, IgM, and IgA diagnostic kit.
- To compare its results with established Immunofluorescence Assay (IFA) methods for IgG and IgM.
- To assess the kit's specificity regarding common interfering antibodies and its ability to detect antibodies in acute toxoplasma infection.
Summary:
- The Platelia Toxo IgG, IgM, and IgA kit demonstrated high co-positivity when compared to IFA IgG and IgM methods.
- The kit showed no non-specific reactions with sera containing antinuclear antibodies or rheumatoid factor, indicating high specificity.
- The Platelia Toxo IgM and IgA components effectively detected antibodies in patients during the acute stage of laboratory-confirmed or acquired toxoplasma infection.
Impact:
- Provides a reliable and specific diagnostic tool for toxoplasma infections.
- Enhances the accuracy of diagnosing acute toxoplasma infections, particularly by detecting IgM and IgA antibodies.
- Offers a potential improvement over existing diagnostic methods, reducing false positives and improving early detection.
More Related Videos
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
09:49Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
Published on: April 29, 2020
